Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
03 Nov 2017 FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Nov 2017 Predictive Model May Determine Risk of Subsequent CNS Tumour in Survivors of Childhood Cancer Central nervous system malignancies - Translational research - Cancer in Special Situations
01 Nov 2017 ESMO Media Alert: It is Time for a Concerted European Approach to Defeat Cancer
30 Oct 2017 Rolapitant i.v. Approved by FDA for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy Palliative and supportive care
27 Oct 2017 NICE Announce Nivolumab To Be Available for Some Patients with Head and Neck Cancer Head and neck cancers - Cancer Immunology and Immunotherapy
26 Oct 2017 ASTRO 2017: External Beam Radiotherapy Plus Two Different Fractionation Schedules of High-Dose Rate Brachytherapy for Cervical Cancer Gynaecologic malignancies
25 Oct 2017 ASTRO 2017: Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin in Patients with High-Risk, Early-Stage Endometrial Cancer Gynaecologic malignancies
24 Oct 2017 IASLC WCLC 2017: Patient-Reported Outcomes in the PACIFIC Study Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
23 Oct 2017 Data Privacy in the Age of Big Data Bioethics, legal and economic issues - Personalised medicine
20 Oct 2017 FDA Approves Axicabtagene Ciloleucel for Large B-Cell Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy
20 Oct 2017 Annals of Oncology Press Release: Oral Sex and Smoking Increase Men’s Risk of Head and Neck Cancer But the Risk is Still Low, Making Screening for the Disease a Challenge
19 Oct 2017 Precision Medicine Experts Exploit Multiple Mutations to Improve Cancer Treatment Translational research - Personalised medicine
18 Oct 2017 EMA Recommends Extension of Indications for Fulvestrant Breast cancer - Anticancer agents & Biologic therapy
17 Oct 2017 EMA Recommends Extension of Indications for Abiraterone Acetate Genitourinary cancers - Anticancer agents & Biologic therapy
16 Oct 2017 EMA Recommends Extension of Indications for Alectinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy